Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-TNF Discontinuation in IBD
NCT02994836Phase 4Completed
- Sponsor
- Fundación de Investigación Biomédica del Hospital Universitario de La Princesa
- Start
- Apr 2017
- Primary completion
- Dec 2021
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab, adalimumab in Crohn's disease, ulcerative colitis (UC), sponsored by Fundación de Investigación Biomédica del Hospital Universitario de La Princesa. Started Apr 2017; status: completed.
02
Drugs
infliximabadalimumab
03
Conditions
Crohn's diseaseulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02994836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02994836.